| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 106 | 2024 | 6566 | 3.290 |
Why?
|
| Hospitals | 58 | 2024 | 3954 | 2.160 |
Why?
|
| Quality of Health Care | 45 | 2023 | 4369 | 1.660 |
Why?
|
| Reimbursement Mechanisms | 12 | 2023 | 670 | 1.290 |
Why?
|
| Cardiomyopathy, Hypertrophic | 17 | 2023 | 1265 | 1.210 |
Why?
|
| Reimbursement, Incentive | 9 | 2020 | 540 | 1.190 |
Why?
|
| Skilled Nursing Facilities | 12 | 2023 | 372 | 1.170 |
Why?
|
| Patient Readmission | 29 | 2023 | 3116 | 1.160 |
Why?
|
| United States | 197 | 2024 | 69872 | 1.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2014 | 689 | 1.080 |
Why?
|
| Medicaid | 23 | 2024 | 2737 | 1.050 |
Why?
|
| Independent Living | 14 | 2023 | 568 | 1.000 |
Why?
|
| Health Expenditures | 19 | 2023 | 2349 | 0.980 |
Why?
|
| Patient Satisfaction | 26 | 2020 | 3395 | 0.940 |
Why?
|
| Aged | 262 | 2024 | 163288 | 0.910 |
Why?
|
| Sarcomeres | 9 | 2019 | 374 | 0.870 |
Why?
|
| Primary Health Care | 30 | 2023 | 4557 | 0.840 |
Why?
|
| Insurance Coverage | 16 | 2022 | 1900 | 0.810 |
Why?
|
| Hospital Administration | 8 | 2019 | 353 | 0.810 |
Why?
|
| Female | 403 | 2024 | 380193 | 0.800 |
Why?
|
| Humans | 553 | 2024 | 744366 | 0.770 |
Why?
|
| Ambulatory Care | 23 | 2020 | 2708 | 0.760 |
Why?
|
| Male | 365 | 2024 | 350115 | 0.750 |
Why?
|
| Hospital Mortality | 27 | 2023 | 5316 | 0.750 |
Why?
|
| Medicare Part C | 5 | 2023 | 296 | 0.740 |
Why?
|
| Somatoform Disorders | 7 | 2013 | 423 | 0.730 |
Why?
|
| Cholecalciferol | 9 | 2024 | 535 | 0.730 |
Why?
|
| Myelodysplastic Syndromes | 5 | 2014 | 1352 | 0.700 |
Why?
|
| Quality Improvement | 15 | 2021 | 3749 | 0.700 |
Why?
|
| Health Care Costs | 17 | 2020 | 3208 | 0.690 |
Why?
|
| Health Services Accessibility | 21 | 2022 | 5135 | 0.680 |
Why?
|
| Frail Elderly | 11 | 2022 | 693 | 0.670 |
Why?
|
| Hip Fractures | 10 | 2020 | 955 | 0.670 |
Why?
|
| Hospitalization | 31 | 2024 | 10259 | 0.670 |
Why?
|
| Medication Reconciliation | 4 | 2023 | 151 | 0.660 |
Why?
|
| Quality Assurance, Health Care | 14 | 2018 | 2212 | 0.640 |
Why?
|
| Aged, 80 and over | 113 | 2024 | 57776 | 0.640 |
Why?
|
| Vitamin D | 15 | 2024 | 3224 | 0.640 |
Why?
|
| Alcoholism | 10 | 2019 | 1906 | 0.630 |
Why?
|
| Quality Indicators, Health Care | 14 | 2021 | 1831 | 0.620 |
Why?
|
| Medical Records Systems, Computerized | 15 | 2009 | 1205 | 0.620 |
Why?
|
| Cardiomyopathy, Dilated | 9 | 2024 | 851 | 0.620 |
Why?
|
| Anemia, Iron-Deficiency | 4 | 2022 | 365 | 0.610 |
Why?
|
| Patient Protection and Affordable Care Act | 12 | 2022 | 1209 | 0.610 |
Why?
|
| Healthcare Disparities | 15 | 2021 | 3154 | 0.610 |
Why?
|
| Pneumonia | 17 | 2020 | 2133 | 0.600 |
Why?
|
| Accidental Falls | 8 | 2022 | 1062 | 0.590 |
Why?
|
| Fee-for-Service Plans | 20 | 2023 | 694 | 0.580 |
Why?
|
| Vitamins | 9 | 2024 | 1623 | 0.570 |
Why?
|
| Hospitals, Teaching | 22 | 2024 | 1180 | 0.540 |
Why?
|
| Middle Aged | 201 | 2023 | 213390 | 0.530 |
Why?
|
| Medical Order Entry Systems | 7 | 2018 | 545 | 0.520 |
Why?
|
| Emergency Service, Hospital | 21 | 2023 | 7658 | 0.520 |
Why?
|
| Medication Errors | 8 | 2019 | 798 | 0.520 |
Why?
|
| Dietary Supplements | 13 | 2024 | 3296 | 0.510 |
Why?
|
| Episode of Care | 7 | 2021 | 126 | 0.510 |
Why?
|
| Minority Groups | 5 | 2021 | 1221 | 0.490 |
Why?
|
| Patient Discharge | 16 | 2023 | 3318 | 0.490 |
Why?
|
| Adult | 195 | 2023 | 214052 | 0.490 |
Why?
|
| Myocardial Infarction | 25 | 2023 | 11718 | 0.480 |
Why?
|
| Coronary Artery Bypass | 5 | 2020 | 2288 | 0.470 |
Why?
|
| Poverty | 10 | 2022 | 2660 | 0.460 |
Why?
|
| Private Sector | 2 | 2016 | 392 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 10 | 2024 | 3020 | 0.450 |
Why?
|
| Patient Admission | 6 | 2018 | 1380 | 0.440 |
Why?
|
| Psychotherapy, Brief | 3 | 2011 | 114 | 0.440 |
Why?
|
| Heart Failure | 29 | 2023 | 10895 | 0.440 |
Why?
|
| Physicians | 14 | 2022 | 4567 | 0.440 |
Why?
|
| Subacute Care | 6 | 2022 | 168 | 0.430 |
Why?
|
| Health Care Surveys | 22 | 2019 | 2453 | 0.430 |
Why?
|
| Alcohol Drinking | 10 | 2017 | 3966 | 0.430 |
Why?
|
| Surgical Procedures, Operative | 9 | 2020 | 1877 | 0.420 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2024 | 1344 | 0.420 |
Why?
|
| Economics, Hospital | 5 | 2021 | 213 | 0.420 |
Why?
|
| Quality of Life | 29 | 2022 | 12802 | 0.420 |
Why?
|
| Massachusetts | 40 | 2019 | 8662 | 0.420 |
Why?
|
| Arthroplasty, Replacement | 3 | 2021 | 339 | 0.410 |
Why?
|
| Length of Stay | 15 | 2023 | 6311 | 0.400 |
Why?
|
| Razoxane | 2 | 2010 | 44 | 0.400 |
Why?
|
| Employment | 6 | 2022 | 1132 | 0.400 |
Why?
|
| Malpractice | 8 | 2017 | 572 | 0.400 |
Why?
|
| Medically Uninsured | 6 | 2021 | 853 | 0.400 |
Why?
|
| Sick Sinus Syndrome | 6 | 2009 | 44 | 0.390 |
Why?
|
| Hospitalists | 4 | 2022 | 305 | 0.390 |
Why?
|
| Electronic Health Records | 18 | 2023 | 4468 | 0.380 |
Why?
|
| Health Status | 12 | 2022 | 4034 | 0.360 |
Why?
|
| Temperance | 2 | 2006 | 89 | 0.360 |
Why?
|
| Mental Disorders | 10 | 2022 | 6598 | 0.360 |
Why?
|
| Prospective Studies | 79 | 2024 | 53290 | 0.360 |
Why?
|
| Urinalysis | 3 | 2021 | 369 | 0.360 |
Why?
|
| Patient Transfer | 5 | 2023 | 762 | 0.360 |
Why?
|
| Risk-Taking | 4 | 2011 | 986 | 0.350 |
Why?
|
| Multivariate Analysis | 37 | 2018 | 12244 | 0.350 |
Why?
|
| Health Services Research | 14 | 2018 | 1836 | 0.340 |
Why?
|
| Hospitals, Rural | 3 | 2020 | 172 | 0.340 |
Why?
|
| Cross-Sectional Studies | 40 | 2024 | 25039 | 0.340 |
Why?
|
| Hospital Costs | 8 | 2019 | 985 | 0.340 |
Why?
|
| Diffusion of Innovation | 10 | 2016 | 725 | 0.340 |
Why?
|
| Switzerland | 9 | 2020 | 256 | 0.340 |
Why?
|
| Medicare Part D | 2 | 2024 | 328 | 0.340 |
Why?
|
| Hospitals, Proprietary | 5 | 2015 | 39 | 0.340 |
Why?
|
| Cost Savings | 7 | 2022 | 925 | 0.330 |
Why?
|
| Guideline Adherence | 10 | 2021 | 2265 | 0.320 |
Why?
|
| Substance Abuse Detection | 3 | 2021 | 283 | 0.320 |
Why?
|
| Hypertrophy, Left Ventricular | 8 | 2023 | 857 | 0.320 |
Why?
|
| Vitamin D Deficiency | 7 | 2019 | 1343 | 0.320 |
Why?
|
| Cohort Studies | 52 | 2023 | 40559 | 0.320 |
Why?
|
| Delirium | 9 | 2010 | 1610 | 0.320 |
Why?
|
| Diagnosis-Related Groups | 4 | 2021 | 455 | 0.320 |
Why?
|
| Retrospective Studies | 69 | 2024 | 77460 | 0.320 |
Why?
|
| Practice Management, Medical | 5 | 2008 | 196 | 0.310 |
Why?
|
| Physicians, Primary Care | 4 | 2018 | 592 | 0.310 |
Why?
|
| Reminder Systems | 3 | 2023 | 371 | 0.310 |
Why?
|
| Mortality | 10 | 2021 | 2864 | 0.310 |
Why?
|
| Prescription Drugs | 4 | 2022 | 595 | 0.310 |
Why?
|
| Home Care Services | 3 | 2022 | 606 | 0.310 |
Why?
|
| Sibling Relations | 1 | 2007 | 45 | 0.300 |
Why?
|
| Health Services for the Aged | 3 | 2020 | 269 | 0.300 |
Why?
|
| Follow-Up Studies | 51 | 2021 | 39052 | 0.300 |
Why?
|
| Pregnancy Complications | 8 | 2022 | 2861 | 0.300 |
Why?
|
| Cardiac Pacing, Artificial | 9 | 2006 | 845 | 0.300 |
Why?
|
| Ventricular Function, Left | 12 | 2024 | 3666 | 0.290 |
Why?
|
| Double-Blind Method | 25 | 2024 | 12025 | 0.290 |
Why?
|
| Hospitals, Voluntary | 3 | 2014 | 40 | 0.290 |
Why?
|
| Telephone | 4 | 2023 | 617 | 0.280 |
Why?
|
| Geriatric Assessment | 8 | 2022 | 1372 | 0.280 |
Why?
|
| Body Composition | 5 | 2018 | 2402 | 0.280 |
Why?
|
| Hospitals, Community | 4 | 2023 | 347 | 0.280 |
Why?
|
| Calcifediol | 2 | 2019 | 166 | 0.280 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 5321 | 0.280 |
Why?
|
| Diet, Mediterranean | 2 | 2024 | 700 | 0.280 |
Why?
|
| Postural Balance | 3 | 2020 | 620 | 0.280 |
Why?
|
| Group Practice | 4 | 2021 | 149 | 0.280 |
Why?
|
| Multiple Sclerosis | 20 | 2005 | 3079 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2021 | 1458 | 0.280 |
Why?
|
| HIV Infections | 24 | 2022 | 16715 | 0.270 |
Why?
|
| Exercise Therapy | 4 | 2024 | 904 | 0.270 |
Why?
|
| Substance-Related Disorders | 10 | 2019 | 4257 | 0.270 |
Why?
|
| Self Report | 3 | 2018 | 3553 | 0.270 |
Why?
|
| Arkansas | 4 | 2020 | 52 | 0.260 |
Why?
|
| Health Care Reform | 4 | 2017 | 1261 | 0.260 |
Why?
|
| Treatment Outcome | 41 | 2020 | 63107 | 0.260 |
Why?
|
| Internal Medicine | 5 | 2019 | 1009 | 0.260 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2019 | 451 | 0.260 |
Why?
|
| Medical Records | 2 | 2010 | 1413 | 0.260 |
Why?
|
| Eligibility Determination | 3 | 2023 | 403 | 0.250 |
Why?
|
| Hospitals, Urban | 9 | 2014 | 499 | 0.250 |
Why?
|
| Neuropsychological Tests | 5 | 2014 | 6994 | 0.250 |
Why?
|
| Time Factors | 32 | 2023 | 40075 | 0.250 |
Why?
|
| Logistic Models | 26 | 2020 | 13409 | 0.250 |
Why?
|
| Boston | 29 | 2020 | 9312 | 0.250 |
Why?
|
| Pacemaker, Artificial | 8 | 2009 | 816 | 0.250 |
Why?
|
| Ownership | 5 | 2021 | 332 | 0.250 |
Why?
|
| Decision Support Systems, Clinical | 5 | 2018 | 1164 | 0.250 |
Why?
|
| Insurance, Health | 9 | 2022 | 2494 | 0.250 |
Why?
|
| Chest Pain | 6 | 2021 | 1114 | 0.250 |
Why?
|
| Efficiency, Organizational | 4 | 2015 | 695 | 0.240 |
Why?
|
| Patient Care | 3 | 2022 | 640 | 0.240 |
Why?
|
| Child | 65 | 2024 | 77709 | 0.240 |
Why?
|
| Ventricular Remodeling | 3 | 2024 | 1223 | 0.240 |
Why?
|
| Mass Screening | 8 | 2023 | 5253 | 0.240 |
Why?
|
| Insurance Carriers | 2 | 2022 | 157 | 0.230 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2020 | 456 | 0.230 |
Why?
|
| United States Indian Health Service | 2 | 2016 | 32 | 0.230 |
Why?
|
| Inpatients | 6 | 2022 | 2518 | 0.230 |
Why?
|
| Young Adult | 40 | 2021 | 56429 | 0.230 |
Why?
|
| Data Collection | 12 | 2018 | 3339 | 0.230 |
Why?
|
| Patient-Centered Care | 5 | 2020 | 1438 | 0.230 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2020 | 783 | 0.230 |
Why?
|
| Cardiomyopathies | 5 | 2024 | 1912 | 0.230 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 934 | 0.220 |
Why?
|
| Age Factors | 23 | 2020 | 18373 | 0.220 |
Why?
|
| Hypertension | 8 | 2024 | 8479 | 0.220 |
Why?
|
| Risk Management | 4 | 2017 | 571 | 0.220 |
Why?
|
| Neoplasms | 13 | 2023 | 21696 | 0.220 |
Why?
|
| Appointments and Schedules | 3 | 2020 | 417 | 0.220 |
Why?
|
| Academic Medical Centers | 10 | 2023 | 2760 | 0.220 |
Why?
|
| Risk Factors | 57 | 2023 | 72296 | 0.220 |
Why?
|
| Child, Preschool | 49 | 2021 | 41005 | 0.220 |
Why?
|
| Adolescent | 62 | 2023 | 85779 | 0.220 |
Why?
|
| Health Maintenance Organizations | 6 | 2023 | 642 | 0.220 |
Why?
|
| Cognition | 6 | 2020 | 6770 | 0.220 |
Why?
|
| Attitude of Health Personnel | 9 | 2015 | 3841 | 0.220 |
Why?
|
| Anemia | 2 | 2022 | 1503 | 0.220 |
Why?
|
| Arthroplasty, Replacement, Hip | 4 | 2021 | 1462 | 0.210 |
Why?
|
| Competitive Bidding | 1 | 2022 | 17 | 0.210 |
Why?
|
| Registries | 16 | 2024 | 8091 | 0.210 |
Why?
|
| Activities of Daily Living | 13 | 2022 | 2419 | 0.210 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1796 | 0.210 |
Why?
|
| Echocardiography | 19 | 2020 | 5099 | 0.210 |
Why?
|
| Referral and Consultation | 7 | 2018 | 3531 | 0.200 |
Why?
|
| Coronary Restenosis | 4 | 2005 | 424 | 0.200 |
Why?
|
| Body Mass Index | 13 | 2021 | 12721 | 0.200 |
Why?
|
| Cognition Disorders | 4 | 2020 | 4043 | 0.200 |
Why?
|
| Texas | 3 | 2020 | 391 | 0.200 |
Why?
|
| Dairy Products | 2 | 2016 | 498 | 0.200 |
Why?
|
| Myocardial Ischemia | 6 | 2021 | 2148 | 0.200 |
Why?
|
| Costs and Cost Analysis | 6 | 2023 | 1680 | 0.200 |
Why?
|
| Physicians, Family | 6 | 2005 | 345 | 0.200 |
Why?
|
| Indians, North American | 2 | 2018 | 355 | 0.200 |
Why?
|
| Safety Management | 4 | 2015 | 783 | 0.190 |
Why?
|
| Parents | 4 | 2020 | 3405 | 0.190 |
Why?
|
| Health Facility Administrators | 1 | 2021 | 31 | 0.190 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 342 | 0.190 |
Why?
|
| Physician-Patient Relations | 5 | 2015 | 3229 | 0.190 |
Why?
|
| Dance Therapy | 1 | 2020 | 8 | 0.190 |
Why?
|
| Electronic Prescribing | 2 | 2019 | 121 | 0.190 |
Why?
|
| Colorectal Neoplasms | 7 | 2023 | 6773 | 0.190 |
Why?
|
| Adenoma | 3 | 2019 | 2174 | 0.190 |
Why?
|
| Mass Behavior | 1 | 2000 | 12 | 0.190 |
Why?
|
| Regression Analysis | 19 | 2021 | 6459 | 0.190 |
Why?
|
| Schools, Medical | 2 | 2018 | 881 | 0.190 |
Why?
|
| Prescriptions | 2 | 2021 | 387 | 0.190 |
Why?
|
| Aftercare | 3 | 2023 | 870 | 0.190 |
Why?
|
| Medical Errors | 8 | 2009 | 1297 | 0.190 |
Why?
|
| Longitudinal Studies | 21 | 2020 | 13991 | 0.190 |
Why?
|
| Diabetes Mellitus | 7 | 2020 | 5749 | 0.190 |
Why?
|
| Incidence | 29 | 2022 | 20952 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 2 | 2007 | 1062 | 0.190 |
Why?
|
| Patients | 5 | 2023 | 900 | 0.190 |
Why?
|
| Health Communication | 1 | 2023 | 214 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2017 | 964 | 0.180 |
Why?
|
| Patient Selection | 5 | 2021 | 4216 | 0.180 |
Why?
|
| Health Records, Personal | 2 | 2013 | 124 | 0.180 |
Why?
|
| Adipose Tissue | 3 | 2017 | 3280 | 0.180 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3086 | 0.180 |
Why?
|
| Analgesics, Opioid | 4 | 2021 | 3677 | 0.180 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.180 |
Why?
|
| Pandemics | 14 | 2023 | 8385 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2021 | 9955 | 0.180 |
Why?
|
| Unnecessary Procedures | 2 | 2020 | 432 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 441 | 0.180 |
Why?
|
| Risk | 14 | 2017 | 9688 | 0.180 |
Why?
|
| Heart | 7 | 2021 | 4464 | 0.180 |
Why?
|
| Predictive Value of Tests | 19 | 2016 | 15078 | 0.180 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2015 | 204 | 0.180 |
Why?
|
| Gift Giving | 1 | 2020 | 80 | 0.170 |
Why?
|
| Patient Participation | 3 | 2016 | 1457 | 0.170 |
Why?
|
| Kentucky | 2 | 2016 | 83 | 0.170 |
Why?
|
| Health Policy | 5 | 2022 | 2661 | 0.170 |
Why?
|
| Postal Service | 4 | 1992 | 96 | 0.170 |
Why?
|
| Pregnancy | 24 | 2022 | 29144 | 0.170 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 1415 | 0.170 |
Why?
|
| Dancing | 1 | 2020 | 101 | 0.170 |
Why?
|
| Nursing Staff | 1 | 2020 | 129 | 0.170 |
Why?
|
| Office Visits | 3 | 2020 | 598 | 0.170 |
Why?
|
| Obesity | 7 | 2020 | 12746 | 0.170 |
Why?
|
| Troponin T | 3 | 2021 | 754 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 6 | 2005 | 2716 | 0.170 |
Why?
|
| Hospital Charges | 2 | 2018 | 362 | 0.170 |
Why?
|
| Physician Incentive Plans | 1 | 2020 | 161 | 0.170 |
Why?
|
| Attitude to Health | 4 | 2020 | 2052 | 0.170 |
Why?
|
| Community Health Planning | 1 | 2019 | 165 | 0.170 |
Why?
|
| Stress, Psychological | 8 | 2011 | 4245 | 0.170 |
Why?
|
| Time and Motion Studies | 3 | 2020 | 149 | 0.170 |
Why?
|
| Outpatients | 2 | 2023 | 1487 | 0.160 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 204 | 0.160 |
Why?
|
| Resistance Training | 1 | 2020 | 164 | 0.160 |
Why?
|
| Hospice Care | 3 | 2022 | 672 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2020 | 397 | 0.160 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2019 | 133 | 0.160 |
Why?
|
| Statistics as Topic | 6 | 2011 | 2373 | 0.160 |
Why?
|
| Attitude to Computers | 6 | 2008 | 202 | 0.160 |
Why?
|
| Homicide | 2 | 2000 | 287 | 0.160 |
Why?
|
| Stents | 5 | 2013 | 3282 | 0.160 |
Why?
|
| Chronic Disease | 10 | 2024 | 9145 | 0.160 |
Why?
|
| Hospital Bed Capacity | 7 | 2017 | 215 | 0.160 |
Why?
|
| Disability Evaluation | 8 | 2020 | 1828 | 0.160 |
Why?
|
| Heart Ventricles | 8 | 2017 | 3817 | 0.160 |
Why?
|
| Iatrogenic Disease | 4 | 2006 | 547 | 0.160 |
Why?
|
| Social Work | 1 | 2019 | 162 | 0.160 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2012 | 469 | 0.160 |
Why?
|
| Cocaine | 4 | 1997 | 1007 | 0.150 |
Why?
|
| Cardiotoxins | 1 | 2017 | 41 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 7 | 2020 | 2073 | 0.150 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 52 | 0.150 |
Why?
|
| Sensitivity and Specificity | 14 | 2019 | 14723 | 0.150 |
Why?
|
| Heptanoic Acids | 3 | 2005 | 343 | 0.150 |
Why?
|
| Risk Adjustment | 4 | 2014 | 594 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 2026 | 0.150 |
Why?
|
| Social Conditions | 1 | 2018 | 126 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2022 | 455 | 0.150 |
Why?
|
| Severity of Illness Index | 15 | 2020 | 15535 | 0.150 |
Why?
|
| Professional-Family Relations | 2 | 2020 | 482 | 0.150 |
Why?
|
| Dietary Fats | 2 | 2016 | 2016 | 0.150 |
Why?
|
| Poisson Distribution | 5 | 2020 | 513 | 0.150 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 976 | 0.150 |
Why?
|
| Behavior Therapy | 2 | 2017 | 865 | 0.150 |
Why?
|
| Thyrotropin | 1 | 2020 | 849 | 0.150 |
Why?
|
| Risk Assessment | 17 | 2022 | 23336 | 0.140 |
Why?
|
| Relaxation Therapy | 2 | 2010 | 178 | 0.140 |
Why?
|
| Specialization | 3 | 2020 | 776 | 0.140 |
Why?
|
| Polypharmacy | 1 | 2019 | 294 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2020 | 10943 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 3922 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2022 | 523 | 0.140 |
Why?
|
| Adiposity | 2 | 2017 | 1806 | 0.140 |
Why?
|
| Blood Pressure | 4 | 2020 | 8551 | 0.140 |
Why?
|
| Confidence Intervals | 8 | 2019 | 2971 | 0.140 |
Why?
|
| Clinical Coding | 1 | 2018 | 171 | 0.140 |
Why?
|
| Music | 1 | 2020 | 263 | 0.140 |
Why?
|
| Developed Countries | 1 | 2019 | 437 | 0.140 |
Why?
|
| Receptors, Transferrin | 3 | 2022 | 296 | 0.140 |
Why?
|
| Social Perception | 1 | 2020 | 425 | 0.140 |
Why?
|
| Internationality | 2 | 2019 | 1002 | 0.140 |
Why?
|
| Pain Measurement | 6 | 2020 | 3420 | 0.140 |
Why?
|
| Postoperative Period | 5 | 2020 | 1842 | 0.140 |
Why?
|
| Continuity of Patient Care | 4 | 2015 | 1049 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 1714 | 0.140 |
Why?
|
| Foreign Medical Graduates | 1 | 2017 | 79 | 0.140 |
Why?
|
| Mentors | 1 | 2021 | 631 | 0.140 |
Why?
|
| Analysis of Variance | 12 | 2013 | 6366 | 0.130 |
Why?
|
| District of Columbia | 1 | 2016 | 157 | 0.130 |
Why?
|
| Cost Control | 2 | 2020 | 624 | 0.130 |
Why?
|
| Cyclophosphamide | 7 | 2005 | 2242 | 0.130 |
Why?
|
| Accreditation | 1 | 2018 | 452 | 0.130 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 2064 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2011 | 812 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2017 | 227 | 0.130 |
Why?
|
| Health Facility Closure | 1 | 2015 | 18 | 0.130 |
Why?
|
| Beverages | 1 | 2021 | 821 | 0.130 |
Why?
|
| Testosterone | 3 | 2020 | 2419 | 0.130 |
Why?
|
| Recovery of Function | 4 | 2019 | 2926 | 0.130 |
Why?
|
| Panic Disorder | 1 | 1999 | 616 | 0.130 |
Why?
|
| Hemoglobins | 4 | 2022 | 1532 | 0.130 |
Why?
|
| Nursing Homes | 2 | 2020 | 1036 | 0.130 |
Why?
|
| Professional Practice | 1 | 2017 | 326 | 0.130 |
Why?
|
| Radiation Oncology | 1 | 2021 | 555 | 0.130 |
Why?
|
| Databases, Factual | 11 | 2021 | 7730 | 0.130 |
Why?
|
| Prevalence | 13 | 2022 | 15221 | 0.130 |
Why?
|
| Critical Care | 4 | 2017 | 2647 | 0.130 |
Why?
|
| Electrocardiography | 9 | 2020 | 6442 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 941 | 0.130 |
Why?
|
| Sex Factors | 13 | 2020 | 10400 | 0.120 |
Why?
|
| Infant, Newborn | 27 | 2022 | 25628 | 0.120 |
Why?
|
| Body Size | 1 | 2017 | 461 | 0.120 |
Why?
|
| Benchmarking | 4 | 2010 | 1042 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 11 | 2019 | 7282 | 0.120 |
Why?
|
| Intensive Care Units | 6 | 2021 | 3680 | 0.120 |
Why?
|
| Coronary Vessels | 5 | 2012 | 3107 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 1996 | 147 | 0.120 |
Why?
|
| Fractures, Bone | 5 | 2020 | 1947 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2019 | 689 | 0.120 |
Why?
|
| Cannabis | 2 | 2011 | 440 | 0.120 |
Why?
|
| Angina Pectoris | 5 | 2005 | 977 | 0.120 |
Why?
|
| Colistin | 1 | 2014 | 47 | 0.120 |
Why?
|
| Hospitals, Public | 2 | 2014 | 207 | 0.120 |
Why?
|
| Chief Executive Officers, Hospital | 1 | 2014 | 9 | 0.120 |
Why?
|
| Cause of Death | 7 | 2018 | 3582 | 0.120 |
Why?
|
| Diltiazem | 1 | 2014 | 133 | 0.120 |
Why?
|
| Infant | 35 | 2020 | 35134 | 0.120 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 15160 | 0.120 |
Why?
|
| beta-Lactam Resistance | 1 | 2014 | 79 | 0.120 |
Why?
|
| Stroke | 5 | 2024 | 9981 | 0.120 |
Why?
|
| Heart Transplantation | 7 | 2015 | 3112 | 0.120 |
Why?
|
| Heterozygote | 3 | 2018 | 2804 | 0.120 |
Why?
|
| Survival Rate | 13 | 2021 | 12788 | 0.120 |
Why?
|
| Violence | 1 | 2000 | 909 | 0.120 |
Why?
|
| Infertility | 2 | 2011 | 655 | 0.120 |
Why?
|
| Coronary Artery Disease | 6 | 2020 | 6486 | 0.120 |
Why?
|
| Calcium, Dietary | 2 | 2014 | 526 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 199 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 7 | 1993 | 648 | 0.120 |
Why?
|
| Drug Industry | 1 | 2020 | 746 | 0.120 |
Why?
|
| Clinical Competence | 5 | 2018 | 4687 | 0.120 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2016 | 402 | 0.120 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 3611 | 0.120 |
Why?
|
| Myocardial Contraction | 4 | 2012 | 1579 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2017 | 1872 | 0.110 |
Why?
|
| Carbapenems | 1 | 2014 | 118 | 0.110 |
Why?
|
| Computers | 1 | 2016 | 612 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 965 | 0.110 |
Why?
|
| Selection Bias | 1 | 1995 | 371 | 0.110 |
Why?
|
| Research Design | 6 | 2015 | 5984 | 0.110 |
Why?
|
| Spouses | 2 | 2006 | 286 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2017 | 3255 | 0.110 |
Why?
|
| Patient Education as Topic | 5 | 2016 | 2278 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2010 | 3712 | 0.110 |
Why?
|
| Mental Health | 4 | 2019 | 3010 | 0.110 |
Why?
|
| Linear Models | 9 | 2019 | 5953 | 0.110 |
Why?
|
| Mental Health Services | 2 | 2020 | 1644 | 0.110 |
Why?
|
| Terminal Care | 3 | 2021 | 1694 | 0.110 |
Why?
|
| Medical Staff, Hospital | 3 | 2012 | 601 | 0.110 |
Why?
|
| Institutionalization | 1 | 2013 | 104 | 0.110 |
Why?
|
| Uncompensated Care | 1 | 2013 | 34 | 0.110 |
Why?
|
| Proportional Hazards Models | 12 | 2019 | 12356 | 0.110 |
Why?
|
| Pyrroles | 3 | 2005 | 1146 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 2 | 2020 | 1222 | 0.110 |
Why?
|
| Environment | 1 | 2019 | 1123 | 0.110 |
Why?
|
| Acute Disease | 8 | 2014 | 7147 | 0.110 |
Why?
|
| Lung Neoplasms | 6 | 2023 | 13104 | 0.110 |
Why?
|
| Pediatrics | 4 | 2020 | 3475 | 0.110 |
Why?
|
| Internet | 4 | 2020 | 3056 | 0.110 |
Why?
|
| Social Support | 2 | 2017 | 2118 | 0.110 |
Why?
|
| Health Services Misuse | 3 | 2013 | 243 | 0.110 |
Why?
|
| Public Health | 3 | 2024 | 2602 | 0.110 |
Why?
|
| Hypochondriasis | 1 | 2013 | 92 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 952 | 0.110 |
Why?
|
| Gonadotropins | 2 | 1993 | 241 | 0.110 |
Why?
|
| Overweight | 3 | 2020 | 2371 | 0.110 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2014 | 232 | 0.110 |
Why?
|
| Mutation | 8 | 2019 | 29786 | 0.110 |
Why?
|
| Fires | 1 | 2014 | 173 | 0.110 |
Why?
|
| Weight Loss | 2 | 2021 | 2625 | 0.110 |
Why?
|
| Income | 8 | 2020 | 1913 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1236 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 11726 | 0.110 |
Why?
|
| Insurance Claim Review | 5 | 2018 | 720 | 0.100 |
Why?
|
| Breast Neoplasms | 11 | 2020 | 20824 | 0.100 |
Why?
|
| Prenatal Care | 6 | 2011 | 1092 | 0.100 |
Why?
|
| Case-Control Studies | 15 | 2021 | 21748 | 0.100 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 68 | 0.100 |
Why?
|
| Critical Illness | 3 | 2018 | 2670 | 0.100 |
Why?
|
| Managed Care Programs | 1 | 2017 | 950 | 0.100 |
Why?
|
| Product Labeling | 1 | 2012 | 79 | 0.100 |
Why?
|
| Comorbidity | 7 | 2011 | 10388 | 0.100 |
Why?
|
| Nursing Assessment | 3 | 2010 | 107 | 0.100 |
Why?
|
| Death | 3 | 2022 | 678 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2019 | 1367 | 0.100 |
Why?
|
| Maternal Exposure | 2 | 2011 | 961 | 0.100 |
Why?
|
| Myocardium | 5 | 2023 | 4772 | 0.100 |
Why?
|
| Mandatory Reporting | 1 | 2012 | 121 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2010 | 692 | 0.100 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2014 | 264 | 0.100 |
Why?
|
| Medical Audit | 6 | 2012 | 467 | 0.100 |
Why?
|
| International Cooperation | 1 | 2018 | 1420 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2014 | 692 | 0.100 |
Why?
|
| Clinical Alarms | 1 | 2011 | 52 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 165 | 0.100 |
Why?
|
| Pyridines | 2 | 2013 | 2825 | 0.100 |
Why?
|
| Single-Blind Method | 8 | 2017 | 1590 | 0.100 |
Why?
|
| State Health Plans | 1 | 2013 | 216 | 0.100 |
Why?
|
| Dental Care for Aged | 1 | 1990 | 34 | 0.100 |
Why?
|
| Fatty Acids | 2 | 2016 | 1809 | 0.100 |
Why?
|
| Mental Status Schedule | 3 | 2010 | 321 | 0.100 |
Why?
|
| Pregnancy, High-Risk | 2 | 2015 | 120 | 0.100 |
Why?
|
| Crowding | 1 | 2012 | 145 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1997 | 868 | 0.090 |
Why?
|
| Personality | 2 | 2008 | 552 | 0.090 |
Why?
|
| Health Services | 2 | 2006 | 758 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1074 | 0.090 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 4 | 2005 | 518 | 0.090 |
Why?
|
| Locomotion | 2 | 1995 | 378 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2539 | 0.090 |
Why?
|
| Survival Analysis | 12 | 2017 | 10252 | 0.090 |
Why?
|
| Odds Ratio | 13 | 2018 | 9849 | 0.090 |
Why?
|
| Postoperative Complications | 7 | 2018 | 15297 | 0.090 |
Why?
|
| Chi-Square Distribution | 8 | 2011 | 3508 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 290 | 0.090 |
Why?
|
| Community Health Services | 2 | 2013 | 650 | 0.090 |
Why?
|
| Employee Performance Appraisal | 1 | 1990 | 87 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5445 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 271 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2014 | 416 | 0.090 |
Why?
|
| Workers' Compensation | 1 | 1991 | 152 | 0.090 |
Why?
|
| Residence Characteristics | 3 | 2018 | 2050 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 167 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 326 | 0.090 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 75 | 0.090 |
Why?
|
| Social Adjustment | 2 | 2007 | 631 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2018 | 1491 | 0.090 |
Why?
|
| Medical Record Linkage | 2 | 2009 | 284 | 0.090 |
Why?
|
| Drinking | 1 | 2011 | 197 | 0.090 |
Why?
|
| Environment Design | 1 | 2011 | 178 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2003 | 2232 | 0.090 |
Why?
|
| Pregnancy in Adolescence | 1 | 2011 | 158 | 0.090 |
Why?
|
| Angioplasty | 1 | 2012 | 364 | 0.090 |
Why?
|
| Exercise | 3 | 2022 | 5615 | 0.090 |
Why?
|
| Coronary Disease | 6 | 2012 | 6077 | 0.090 |
Why?
|
| Ferritins | 2 | 2022 | 590 | 0.090 |
Why?
|
| Dementia | 1 | 2023 | 2518 | 0.090 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4639 | 0.090 |
Why?
|
| MEDLINE | 2 | 2006 | 125 | 0.090 |
Why?
|
| Cardiovascular Agents | 2 | 2010 | 850 | 0.090 |
Why?
|
| Hospices | 2 | 2016 | 265 | 0.080 |
Why?
|
| Anticholesteremic Agents | 3 | 2004 | 979 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 2 | 1997 | 1170 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 1990 | 211 | 0.080 |
Why?
|
| Hematocrit | 3 | 2000 | 636 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2020 | 2267 | 0.080 |
Why?
|
| California | 5 | 2019 | 1402 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 2020 | 0.080 |
Why?
|
| Workload | 3 | 2008 | 849 | 0.080 |
Why?
|
| Plasma Exchange | 1 | 1989 | 152 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2009 | 86 | 0.080 |
Why?
|
| Anthropometry | 6 | 2018 | 1350 | 0.080 |
Why?
|
| Diastole | 3 | 2020 | 791 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2012 | 545 | 0.080 |
Why?
|
| Lower Extremity | 3 | 2020 | 1158 | 0.080 |
Why?
|
| Demography | 2 | 2019 | 1655 | 0.080 |
Why?
|
| Osteoporosis | 2 | 2011 | 1579 | 0.080 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 19905 | 0.080 |
Why?
|
| C-Reactive Protein | 4 | 2024 | 3778 | 0.080 |
Why?
|
| Nutrition Surveys | 5 | 2018 | 1660 | 0.080 |
Why?
|
| Doxorubicin | 2 | 2010 | 2234 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 935 | 0.080 |
Why?
|
| Milk | 1 | 2011 | 450 | 0.080 |
Why?
|
| Physical Fitness | 2 | 2020 | 732 | 0.080 |
Why?
|
| Pain, Postoperative | 4 | 2004 | 1643 | 0.080 |
Why?
|
| Mind-Body Therapies | 1 | 2011 | 247 | 0.080 |
Why?
|
| Pregnancy Rate | 1 | 2011 | 643 | 0.080 |
Why?
|
| Antirheumatic Agents | 3 | 2010 | 1338 | 0.080 |
Why?
|
| Family Health | 1 | 2013 | 1281 | 0.080 |
Why?
|
| Canada | 4 | 2019 | 2065 | 0.080 |
Why?
|
| Total Quality Management | 3 | 1999 | 274 | 0.080 |
Why?
|
| Platinum Compounds | 1 | 2008 | 96 | 0.080 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 249 | 0.080 |
Why?
|
| Insurance | 1 | 2009 | 111 | 0.080 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2007 | 86 | 0.080 |
Why?
|
| HIV-1 | 7 | 2010 | 6939 | 0.080 |
Why?
|
| Forecasting | 3 | 2017 | 2951 | 0.080 |
Why?
|
| Adaptation, Psychological | 4 | 2007 | 2575 | 0.070 |
Why?
|
| Travel | 3 | 2023 | 788 | 0.070 |
Why?
|
| Bradycardia | 2 | 2000 | 307 | 0.070 |
Why?
|
| Socioeconomic Factors | 10 | 2020 | 7785 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2010 | 1520 | 0.070 |
Why?
|
| Amines | 1 | 2009 | 276 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2023 | 17446 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2015 | 1365 | 0.070 |
Why?
|
| Cholesterol, LDL | 4 | 2008 | 2355 | 0.070 |
Why?
|
| HTLV-I Infections | 2 | 2000 | 101 | 0.070 |
Why?
|
| HIV Seropositivity | 3 | 2011 | 971 | 0.070 |
Why?
|
| Zidovudine | 3 | 2000 | 620 | 0.070 |
Why?
|
| Scientific Misconduct | 1 | 2007 | 71 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2400 | 0.070 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2007 | 295 | 0.070 |
Why?
|
| Waiting Lists | 1 | 2011 | 692 | 0.070 |
Why?
|
| General Surgery | 1 | 2018 | 1636 | 0.070 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 2047 | 0.070 |
Why?
|
| Patient Access to Records | 1 | 2007 | 118 | 0.070 |
Why?
|
| Models, Biological | 6 | 2017 | 9584 | 0.070 |
Why?
|
| Antioxidants | 2 | 2005 | 1659 | 0.070 |
Why?
|
| Statistics, Nonparametric | 6 | 2018 | 2887 | 0.070 |
Why?
|
| Social Isolation | 1 | 2009 | 365 | 0.070 |
Why?
|
| Hypogonadism | 1 | 1992 | 799 | 0.070 |
Why?
|
| Prognosis | 13 | 2017 | 29060 | 0.070 |
Why?
|
| Personality Inventory | 2 | 2007 | 1030 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2010 | 550 | 0.070 |
Why?
|
| Pilot Projects | 7 | 2018 | 8319 | 0.070 |
Why?
|
| Communication | 4 | 2019 | 3750 | 0.070 |
Why?
|
| Calcium | 3 | 2012 | 5755 | 0.070 |
Why?
|
| Culture | 1 | 2010 | 633 | 0.070 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2020 | 500 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 2282 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2021 | 8642 | 0.070 |
Why?
|
| Medical History Taking | 3 | 2019 | 784 | 0.070 |
Why?
|
| Cardiology | 3 | 2009 | 1668 | 0.070 |
Why?
|
| Seasons | 2 | 2013 | 1493 | 0.070 |
Why?
|
| Weather | 1 | 2007 | 228 | 0.070 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2005 | 10 | 0.070 |
Why?
|
| Caregivers | 1 | 2017 | 2095 | 0.070 |
Why?
|
| Hospital-Patient Relations | 1 | 2005 | 16 | 0.070 |
Why?
|
| Growth | 2 | 2001 | 376 | 0.070 |
Why?
|
| Meat | 1 | 2009 | 592 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2014 | 1161 | 0.070 |
Why?
|
| Job Satisfaction | 1 | 2009 | 534 | 0.070 |
Why?
|
| Program Evaluation | 3 | 2020 | 2488 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2008 | 256 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4839 | 0.060 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 239 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1741 | 0.060 |
Why?
|
| Methylprednisolone | 2 | 1999 | 387 | 0.060 |
Why?
|
| Occupational Health | 1 | 1992 | 808 | 0.060 |
Why?
|
| Fever | 1 | 2012 | 1616 | 0.060 |
Why?
|
| Geography | 2 | 2018 | 669 | 0.060 |
Why?
|
| Health Promotion | 1 | 2017 | 2205 | 0.060 |
Why?
|
| Exercise Test | 6 | 2017 | 2073 | 0.060 |
Why?
|
| Drug Implants | 1 | 2005 | 244 | 0.060 |
Why?
|
| Drug Therapy, Combination | 7 | 2013 | 6489 | 0.060 |
Why?
|
| Family Relations | 1 | 2007 | 321 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2011 | 1320 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.060 |
Why?
|
| Communication Barriers | 2 | 2017 | 398 | 0.060 |
Why?
|
| Medicine | 1 | 2013 | 946 | 0.060 |
Why?
|
| Heart Diseases | 4 | 2004 | 2789 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2005 | 1391 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1125 | 0.060 |
Why?
|
| Intelligence | 1 | 2010 | 920 | 0.060 |
Why?
|
| Mood Disorders | 2 | 2005 | 1106 | 0.060 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2004 | 39 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 1342 | 0.060 |
Why?
|
| Triage | 3 | 2011 | 977 | 0.060 |
Why?
|
| Morbidity | 5 | 2011 | 1768 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1162 | 0.060 |
Why?
|
| Health Personnel | 5 | 2018 | 3219 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2005 | 163 | 0.060 |
Why?
|
| Ascorbic Acid | 2 | 2005 | 651 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2200 | 0.060 |
Why?
|
| Acetates | 1 | 2005 | 311 | 0.060 |
Why?
|
| Iron | 2 | 2022 | 1774 | 0.060 |
Why?
|
| Workflow | 1 | 2008 | 847 | 0.060 |
Why?
|
| Chromosomes, Human, X | 1 | 2005 | 296 | 0.060 |
Why?
|
| Models, Economic | 3 | 2016 | 712 | 0.060 |
Why?
|
| Physician's Role | 4 | 2003 | 943 | 0.060 |
Why?
|
| Atrial Fibrillation | 5 | 2009 | 5035 | 0.060 |
Why?
|
| Kidney | 1 | 2019 | 7184 | 0.060 |
Why?
|
| Aspirin | 2 | 2013 | 3283 | 0.060 |
Why?
|
| Interferon-beta | 1 | 2005 | 324 | 0.060 |
Why?
|
| Disease Progression | 10 | 2019 | 13286 | 0.060 |
Why?
|
| Psychomotor Performance | 3 | 2020 | 1901 | 0.060 |
Why?
|
| Terminally Ill | 2 | 2021 | 238 | 0.060 |
Why?
|
| Sex Ratio | 1 | 2004 | 110 | 0.060 |
Why?
|
| Syncope | 2 | 2004 | 429 | 0.060 |
Why?
|
| Intubation | 1 | 2024 | 141 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 1993 | 2055 | 0.060 |
Why?
|
| Fathers | 1 | 2006 | 358 | 0.060 |
Why?
|
| Visual Acuity | 3 | 1999 | 2530 | 0.060 |
Why?
|
| Preventive Health Services | 2 | 2017 | 575 | 0.060 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 3 | 2000 | 236 | 0.060 |
Why?
|
| Androstadienes | 1 | 2005 | 345 | 0.060 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2008 | 496 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2006 | 311 | 0.060 |
Why?
|
| Computer Literacy | 3 | 2008 | 43 | 0.060 |
Why?
|
| HIV | 1 | 2011 | 1604 | 0.060 |
Why?
|
| Myocarditis | 2 | 2011 | 771 | 0.060 |
Why?
|
| Insurance Claim Reporting | 2 | 2001 | 163 | 0.060 |
Why?
|
| Health Status Indicators | 3 | 2001 | 970 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 2011 | 1284 | 0.060 |
Why?
|
| Vitamin E | 2 | 2005 | 869 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2004 | 2765 | 0.060 |
Why?
|
| Needs Assessment | 2 | 2022 | 1147 | 0.060 |
Why?
|
| Smoking | 4 | 2004 | 8987 | 0.060 |
Why?
|
| Surgical Sponges | 1 | 2003 | 46 | 0.050 |
Why?
|
| Cardiotonic Agents | 3 | 2011 | 535 | 0.050 |
Why?
|
| Coronary Angiography | 4 | 2005 | 4576 | 0.050 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 772 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12961 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 6 | 2020 | 5388 | 0.050 |
Why?
|
| Mobility Limitation | 2 | 2017 | 409 | 0.050 |
Why?
|
| Arrhythmia, Sinus | 1 | 2002 | 56 | 0.050 |
Why?
|
| Policy Making | 2 | 2018 | 554 | 0.050 |
Why?
|
| Heart Rate | 6 | 2012 | 4092 | 0.050 |
Why?
|
| Propensity Score | 2 | 2020 | 1781 | 0.050 |
Why?
|
| Bibliometrics | 1 | 2006 | 339 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
| Durable Medical Equipment | 1 | 2022 | 22 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
| Educational Status | 4 | 2015 | 2540 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8038 | 0.050 |
Why?
|
| Lovastatin | 1 | 2002 | 120 | 0.050 |
Why?
|
| Pelvic Bones | 1 | 2004 | 265 | 0.050 |
Why?
|
| Self Concept | 1 | 2008 | 1025 | 0.050 |
Why?
|
| Narcotics | 3 | 1997 | 343 | 0.050 |
Why?
|
| Employee Discipline | 2 | 1992 | 8 | 0.050 |
Why?
|
| Hypercholesterolemia | 2 | 2001 | 1151 | 0.050 |
Why?
|
| Term Birth | 1 | 2022 | 135 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2002 | 296 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2010 | 2269 | 0.050 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2018 | 93 | 0.050 |
Why?
|
| Age Distribution | 3 | 2016 | 2902 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2002 | 144 | 0.050 |
Why?
|
| Homeless Persons | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2005 | 359 | 0.050 |
Why?
|
| Quinazolines | 1 | 2008 | 1356 | 0.050 |
Why?
|
| Body Weight | 3 | 2017 | 4671 | 0.050 |
Why?
|
| Survivors | 2 | 2010 | 2291 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2004 | 411 | 0.050 |
Why?
|
| Subtilisins | 1 | 2021 | 83 | 0.050 |
Why?
|
| Personnel Turnover | 2 | 1992 | 83 | 0.050 |
Why?
|
| Parenting | 1 | 2007 | 679 | 0.050 |
Why?
|
| New Jersey | 4 | 2002 | 290 | 0.050 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2004 | 337 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2001 | 137 | 0.050 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1440 | 0.050 |
Why?
|
| Goals | 1 | 2006 | 707 | 0.050 |
Why?
|
| Choice Behavior | 2 | 2006 | 802 | 0.050 |
Why?
|
| Health Surveys | 4 | 2011 | 4036 | 0.050 |
Why?
|
| Body Height | 2 | 2000 | 1578 | 0.050 |
Why?
|
| New England | 4 | 2012 | 1022 | 0.050 |
Why?
|
| Pharmacists | 1 | 2023 | 248 | 0.050 |
Why?
|
| Cataract Extraction | 2 | 1995 | 481 | 0.050 |
Why?
|
| United States Public Health Service | 1 | 2020 | 31 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 536 | 0.050 |
Why?
|
| Private Practice | 1 | 2021 | 154 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 355 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 1000 | 0.050 |
Why?
|
| Utah | 4 | 2000 | 126 | 0.050 |
Why?
|
| Quinolines | 1 | 2005 | 732 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 292 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2003 | 395 | 0.040 |
Why?
|
| Colorado | 4 | 2000 | 163 | 0.040 |
Why?
|
| Legislation, Hospital | 1 | 2019 | 12 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2001 | 179 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4153 | 0.040 |
Why?
|
| Sex Distribution | 3 | 2013 | 2297 | 0.040 |
Why?
|
| Absenteeism | 2 | 1992 | 250 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2014 | 3265 | 0.040 |
Why?
|
| Accidents, Occupational | 2 | 1992 | 251 | 0.040 |
Why?
|
| Trust | 1 | 2004 | 505 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1999 | 347 | 0.040 |
Why?
|
| Professional Practice Location | 2 | 1996 | 59 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1622 | 0.040 |
Why?
|
| Life Style | 3 | 2021 | 3835 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2000 | 93 | 0.040 |
Why?
|
| Volition | 1 | 2019 | 63 | 0.040 |
Why?
|
| Self-Help Groups | 1 | 2000 | 190 | 0.040 |
Why?
|
| Organizational Culture | 3 | 2008 | 510 | 0.040 |
Why?
|
| Marketing | 1 | 2021 | 212 | 0.040 |
Why?
|
| Pravastatin | 1 | 2001 | 395 | 0.040 |
Why?
|
| Marriage | 2 | 1993 | 339 | 0.040 |
Why?
|
| Fees and Charges | 2 | 2016 | 195 | 0.040 |
Why?
|
| Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 364 | 0.040 |
Why?
|
| Pain | 3 | 2019 | 4988 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2004 | 754 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 11031 | 0.040 |
Why?
|
| Prolactin | 3 | 2002 | 669 | 0.040 |
Why?
|
| Nutritional Status | 2 | 1997 | 1609 | 0.040 |
Why?
|
| Hospital Departments | 2 | 2012 | 137 | 0.040 |
Why?
|
| Mental Recall | 2 | 2018 | 1206 | 0.040 |
Why?
|
| Hotlines | 1 | 2018 | 55 | 0.040 |
Why?
|
| HIV Protease Inhibitors | 1 | 2001 | 430 | 0.040 |
Why?
|
| Language | 2 | 2017 | 1471 | 0.040 |
Why?
|
| Pancreatitis | 2 | 1998 | 1092 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2003 | 400 | 0.040 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2000 | 172 | 0.040 |
Why?
|
| New York | 3 | 2012 | 886 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 7182 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16367 | 0.040 |
Why?
|
| Waist-Hip Ratio | 2 | 2010 | 517 | 0.040 |
Why?
|
| Drug Hypersensitivity | 2 | 2018 | 884 | 0.040 |
Why?
|
| Health Facilities | 1 | 2023 | 572 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 2018 | 203 | 0.040 |
Why?
|
| Safety | 2 | 2014 | 1186 | 0.040 |
Why?
|
| Equipment Design | 5 | 2006 | 3582 | 0.040 |
Why?
|
| Troponin I | 2 | 2014 | 619 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2166 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 707 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 2535 | 0.040 |
Why?
|
| Pets | 1 | 2017 | 29 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 162 | 0.040 |
Why?
|
| Anti-HIV Agents | 3 | 2004 | 4255 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 985 | 0.040 |
Why?
|
| Genotype | 4 | 2017 | 12952 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2506 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2002 | 604 | 0.040 |
Why?
|
| Carrier Proteins | 3 | 2014 | 5023 | 0.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2005 | 1186 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
| Sirolimus | 1 | 2005 | 1565 | 0.040 |
Why?
|
| Fees, Medical | 1 | 2018 | 117 | 0.040 |
Why?
|
| State Government | 1 | 2020 | 372 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 463 | 0.040 |
Why?
|
| Community Health Centers | 3 | 2009 | 430 | 0.040 |
Why?
|
| HIV Core Protein p24 | 1 | 1997 | 256 | 0.040 |
Why?
|
| Data Display | 1 | 1997 | 182 | 0.040 |
Why?
|
| Depressive Disorder | 4 | 2005 | 3747 | 0.040 |
Why?
|
| Weight Gain | 2 | 2000 | 2293 | 0.040 |
Why?
|
| Organizational Affiliation | 1 | 2016 | 33 | 0.040 |
Why?
|
| Longevity | 2 | 2020 | 1071 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2000 | 406 | 0.040 |
Why?
|
| Heart Defects, Congenital | 3 | 2003 | 4583 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 595 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2018 | 1516 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 392 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2016 | 35425 | 0.040 |
Why?
|
| Duodenal Diseases | 1 | 1997 | 102 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 364 | 0.040 |
Why?
|
| Family Practice | 2 | 1996 | 516 | 0.040 |
Why?
|
| Professional Role | 1 | 2019 | 306 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 1889 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 1999 | 572 | 0.030 |
Why?
|
| Indiana | 1 | 2016 | 92 | 0.030 |
Why?
|
| Health Behavior | 2 | 2006 | 2635 | 0.030 |
Why?
|
| Matched-Pair Analysis | 2 | 2013 | 288 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1999 | 549 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2017 | 1725 | 0.030 |
Why?
|
| Depression | 3 | 2005 | 7759 | 0.030 |
Why?
|
| Esophageal Diseases | 1 | 1997 | 167 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2020 | 592 | 0.030 |
Why?
|
| Social Behavior | 1 | 2003 | 1127 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2004 | 1036 | 0.030 |
Why?
|
| Plants | 1 | 2017 | 316 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2002 | 1683 | 0.030 |
Why?
|
| Prospective Payment System | 1 | 2017 | 133 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 404 | 0.030 |
Why?
|
| Recurrence | 6 | 2010 | 8340 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Disabled Persons | 4 | 2016 | 1212 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 214 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 1131 | 0.030 |
Why?
|
| Monocytes | 1 | 2005 | 2596 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1159 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1270 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2000 | 2408 | 0.030 |
Why?
|
| Memory | 2 | 2019 | 2174 | 0.030 |
Why?
|
| Europe | 1 | 2022 | 3338 | 0.030 |
Why?
|
| Transportation | 1 | 2017 | 214 | 0.030 |
Why?
|
| Anxiety Disorders | 3 | 2005 | 2690 | 0.030 |
Why?
|
| Personality Development | 1 | 1996 | 245 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 230 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 724 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 2020 | 544 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1431 | 0.030 |
Why?
|
| Sampling Studies | 2 | 1999 | 623 | 0.030 |
Why?
|
| Financial Management, Hospital | 1 | 2015 | 74 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2003 | 1541 | 0.030 |
Why?
|
| Information Systems | 1 | 2017 | 410 | 0.030 |
Why?
|
| Oxygen | 2 | 2022 | 4189 | 0.030 |
Why?
|
| Cholesterol | 1 | 2024 | 2919 | 0.030 |
Why?
|
| Collagen | 2 | 2013 | 2688 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 1996 | 652 | 0.030 |
Why?
|
| Leadership | 2 | 1996 | 1357 | 0.030 |
Why?
|
| Administration, Oral | 4 | 2009 | 3914 | 0.030 |
Why?
|
| Bone Density | 2 | 2004 | 3468 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Aging | 2 | 2022 | 8664 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2000 | 788 | 0.030 |
Why?
|
| Nutrition Disorders | 2 | 1994 | 211 | 0.030 |
Why?
|
| Nephrology | 1 | 2018 | 263 | 0.030 |
Why?
|
| Feasibility Studies | 4 | 2013 | 5077 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3203 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2000 | 1837 | 0.030 |
Why?
|
| Legislation as Topic | 1 | 2014 | 80 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 1994 | 165 | 0.030 |
Why?
|
| Mammography | 1 | 2005 | 2475 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 917 | 0.030 |
Why?
|
| Spondylitis | 1 | 1993 | 22 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 1637 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 579 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2015 | 187 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2014 | 194 | 0.030 |
Why?
|
| Observer Variation | 4 | 2006 | 2593 | 0.030 |
Why?
|
| Analgesia | 3 | 1998 | 461 | 0.030 |
Why?
|
| Pancreas | 1 | 2000 | 1687 | 0.030 |
Why?
|
| Triamcinolone | 1 | 1993 | 68 | 0.030 |
Why?
|
| Medication Adherence | 2 | 2016 | 2063 | 0.030 |
Why?
|
| Disease Management | 2 | 2016 | 2460 | 0.030 |
Why?
|
| Spinal Nerve Roots | 1 | 1993 | 121 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2009 | 392 | 0.030 |
Why?
|
| Attention | 2 | 2009 | 2397 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3873 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 747 | 0.030 |
Why?
|
| Physicians, Women | 2 | 2017 | 486 | 0.030 |
Why?
|
| Diarrhea | 1 | 2000 | 1348 | 0.030 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 283 | 0.030 |
Why?
|
| Reaction Time | 1 | 2019 | 2098 | 0.030 |
Why?
|
| Psychometrics | 2 | 2020 | 3003 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2019 | 1533 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 219 | 0.030 |
Why?
|
| Arousal | 1 | 1998 | 1164 | 0.030 |
Why?
|
| Parity | 1 | 2015 | 929 | 0.030 |
Why?
|
| Urban Population | 1 | 2020 | 2022 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2004 | 2150 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2008 | 6036 | 0.030 |
Why?
|
| Anxiety | 2 | 2005 | 4293 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 1996 | 421 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 867 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2000 | 2740 | 0.030 |
Why?
|
| Benzodiazepines | 2 | 1997 | 1101 | 0.030 |
Why?
|
| Self-Assessment | 3 | 2001 | 390 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 961 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1995 | 881 | 0.030 |
Why?
|
| Growth Disorders | 3 | 2010 | 645 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 923 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1997 | 612 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 2005 | 7914 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7798 | 0.030 |
Why?
|
| Immune Tolerance | 3 | 1996 | 2259 | 0.030 |
Why?
|
| Macular Degeneration | 1 | 1999 | 980 | 0.030 |
Why?
|
| Rural Health | 1 | 1993 | 305 | 0.030 |
Why?
|
| Ultrasonography | 4 | 2010 | 5984 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2007 | 3524 | 0.020 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 1011 | 0.020 |
Why?
|
| Government Regulation | 1 | 2016 | 522 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1998 | 1359 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2005 | 573 | 0.020 |
Why?
|
| Decision Making | 3 | 2012 | 3888 | 0.020 |
Why?
|
| Homes for the Aged | 1 | 2013 | 260 | 0.020 |
Why?
|
| Dentures | 1 | 1990 | 11 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 288 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6539 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13693 | 0.020 |
Why?
|
| Dental Staff | 1 | 1990 | 14 | 0.020 |
Why?
|
| Models, Econometric | 1 | 1992 | 218 | 0.020 |
Why?
|
| Cost Allocation | 1 | 1991 | 51 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2011 | 103 | 0.020 |
Why?
|
| Injections, Intramuscular | 2 | 1989 | 552 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 1971 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 426 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1995 | 652 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5223 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1994 | 1588 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4459 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2015 | 1460 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 850 | 0.020 |
Why?
|
| Random Allocation | 1 | 1995 | 2428 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 1997 | 1094 | 0.020 |
Why?
|
| Radiculopathy | 1 | 1993 | 197 | 0.020 |
Why?
|
| Biometry | 1 | 1994 | 558 | 0.020 |
Why?
|
| Nursing Diagnosis | 1 | 2010 | 18 | 0.020 |
Why?
|
| San Francisco | 1 | 1990 | 159 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 1991 | 135 | 0.020 |
Why?
|
| Internship and Residency | 2 | 2003 | 5791 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1992 | 744 | 0.020 |
Why?
|
| Fetal Monitoring | 1 | 2010 | 70 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2108 | 0.020 |
Why?
|
| Speech Recognition Software | 1 | 2010 | 72 | 0.020 |
Why?
|
| Carrier State | 1 | 1994 | 518 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1991 | 265 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1992 | 869 | 0.020 |
Why?
|
| Coronary Circulation | 2 | 2003 | 1572 | 0.020 |
Why?
|
| Role | 1 | 1990 | 175 | 0.020 |
Why?
|
| Premenopause | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 836 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 50 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 356 | 0.020 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2011 | 214 | 0.020 |
Why?
|
| Biological Assay | 1 | 1992 | 652 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2000 | 1591 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 366 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 1990 | 344 | 0.020 |
Why?
|
| Occupations | 1 | 1992 | 517 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 253 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 5524 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 1956 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3279 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2009 | 102 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1994 | 963 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2002 | 3057 | 0.020 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1990 | 109 | 0.020 |
Why?
|
| Mathematics | 1 | 1990 | 728 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2838 | 0.020 |
Why?
|
| Housing | 1 | 2014 | 664 | 0.020 |
Why?
|
| Algorithms | 5 | 2013 | 13882 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2010 | 314 | 0.020 |
Why?
|
| Psychology | 1 | 2010 | 356 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2775 | 0.020 |
Why?
|
| Cholesterol, HDL | 2 | 2008 | 1813 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 2006 | 376 | 0.020 |
Why?
|
| Hospitals, Group Practice | 1 | 2008 | 4 | 0.020 |
Why?
|
| Uganda | 1 | 1993 | 1237 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1997 | 2901 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 711 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1401 | 0.020 |
Why?
|
| Autoantigens | 1 | 1993 | 892 | 0.020 |
Why?
|
| Standard of Care | 1 | 2012 | 564 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2001 | 2560 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 2 | 1998 | 115 | 0.020 |
Why?
|
| Reproduction | 1 | 1993 | 668 | 0.020 |
Why?
|
| Social Class | 2 | 2011 | 1997 | 0.020 |
Why?
|
| Obstetrics | 1 | 1995 | 658 | 0.020 |
Why?
|
| Attitude | 1 | 1993 | 776 | 0.020 |
Why?
|
| E-Selectin | 1 | 2010 | 579 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 598 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3464 | 0.020 |
Why?
|
| P-Selectin | 1 | 2010 | 601 | 0.020 |
Why?
|
| Cross Infection | 1 | 1997 | 1417 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 3070 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2022 | 4232 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 619 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 707 | 0.020 |
Why?
|
| Fentanyl | 1 | 1990 | 409 | 0.020 |
Why?
|
| APACHE | 2 | 1998 | 277 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 3046 | 0.020 |
Why?
|
| Health Care Coalitions | 1 | 2007 | 35 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6171 | 0.020 |
Why?
|
| Triglycerides | 2 | 2008 | 2453 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 761 | 0.020 |
Why?
|
| Men's Health | 1 | 2007 | 73 | 0.020 |
Why?
|
| Reference Values | 2 | 2005 | 4982 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2008 | 238 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 894 | 0.020 |
Why?
|
| Aggression | 1 | 2012 | 753 | 0.020 |
Why?
|
| Social Facilitation | 1 | 2006 | 31 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 958 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 976 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11525 | 0.020 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 2000 | 91 | 0.020 |
Why?
|
| Cooking | 1 | 2009 | 313 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2008 | 223 | 0.020 |
Why?
|
| Asthma | 1 | 2005 | 6010 | 0.020 |
Why?
|
| Uncertainty | 1 | 2011 | 735 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2010 | 6896 | 0.020 |
Why?
|
| Patient Care Management | 1 | 2009 | 306 | 0.020 |
Why?
|
| Radiography | 2 | 2013 | 7023 | 0.020 |
Why?
|
| Sexual Partners | 1 | 1990 | 729 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2029 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1084 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1991 | 1254 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2007 | 213 | 0.020 |
Why?
|
| Gestational Age | 2 | 2005 | 3493 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 764 | 0.020 |
Why?
|
| Child Health Services | 1 | 2011 | 667 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2005 | 65 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 346 | 0.020 |
Why?
|
| SEER Program | 2 | 2001 | 1507 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 4386 | 0.020 |
Why?
|
| Manifest Anxiety Scale | 1 | 2005 | 7 | 0.020 |
Why?
|
| Sleep Stages | 2 | 1996 | 686 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
| Bangladesh | 2 | 2000 | 687 | 0.020 |
Why?
|
| Habits | 1 | 2006 | 139 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1990 | 582 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 935 | 0.020 |
Why?
|
| Endometriosis | 1 | 1993 | 839 | 0.020 |
Why?
|
| Nurse-Patient Relations | 1 | 2005 | 101 | 0.020 |
Why?
|
| Sinoatrial Node | 1 | 2005 | 101 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1677 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 2005 | 182 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11126 | 0.020 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2004 | 30 | 0.020 |
Why?
|
| Gender Identity | 1 | 1990 | 687 | 0.020 |
Why?
|
| Sulfides | 1 | 2005 | 165 | 0.020 |
Why?
|
| Vasomotor System | 1 | 2005 | 209 | 0.020 |
Why?
|
| Psychological Tests | 1 | 1987 | 651 | 0.020 |
Why?
|
| Education | 1 | 1987 | 543 | 0.020 |
Why?
|
| Affect | 2 | 2009 | 1475 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4185 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2005 | 457 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 841 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2015 | 2616 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4253 | 0.010 |
Why?
|
| Models, Statistical | 2 | 1996 | 5101 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 4933 | 0.010 |
Why?
|
| Diet Therapy | 1 | 2005 | 154 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1991 | 2715 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 2029 | 0.010 |
Why?
|
| Cyclopropanes | 1 | 2005 | 416 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 528 | 0.010 |
Why?
|
| Prednisone | 1 | 1988 | 1574 | 0.010 |
Why?
|
| Oklahoma | 1 | 2003 | 37 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 2003 | 71 | 0.010 |
Why?
|
| Southwestern United States | 1 | 2003 | 37 | 0.010 |
Why?
|
| Music Therapy | 1 | 2005 | 102 | 0.010 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 391 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2005 | 475 | 0.010 |
Why?
|
| Focus Groups | 1 | 2008 | 1321 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2004 | 165 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 1681 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 2003 | 94 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 1991 | 2307 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 211 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Suicidal Ideation | 1 | 2012 | 1246 | 0.010 |
Why?
|
| Rest | 2 | 1998 | 901 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 302 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4196 | 0.010 |
Why?
|
| Perception | 1 | 2009 | 1198 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2004 | 369 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2110 | 0.010 |
Why?
|
| Leptin | 1 | 2010 | 1600 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2004 | 214 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1105 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1990 | 1469 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 9647 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 1990 | 1078 | 0.010 |
Why?
|
| Maternal Age | 1 | 2005 | 802 | 0.010 |
Why?
|
| Dyspnea | 2 | 2000 | 1303 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3188 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6254 | 0.010 |
Why?
|
| Sleep | 2 | 1996 | 4622 | 0.010 |
Why?
|
| Research | 1 | 1990 | 1999 | 0.010 |
Why?
|
| Treatment Failure | 2 | 1999 | 2618 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 640 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2006 | 705 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10637 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1993 | 2134 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2003 | 613 | 0.010 |
Why?
|
| Intraoperative Complications | 2 | 1998 | 1198 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 1240 | 0.010 |
Why?
|
| Markov Chains | 1 | 2005 | 969 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4042 | 0.010 |
Why?
|
| Reoperation | 2 | 2003 | 4201 | 0.010 |
Why?
|
| Age of Onset | 2 | 1999 | 3270 | 0.010 |
Why?
|
| Menopause | 1 | 2009 | 1626 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2001 | 210 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2003 | 887 | 0.010 |
Why?
|
| Movement | 2 | 1998 | 1471 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1739 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Viral Load | 2 | 2001 | 3300 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2001 | 8861 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1996 | 4446 | 0.010 |
Why?
|
| Energy Intake | 2 | 2001 | 2148 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2005 | 1745 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1994 | 585 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 142 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 141 | 0.010 |
Why?
|
| Telemedicine | 1 | 2017 | 2872 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 944 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2569 | 0.010 |
Why?
|
| Causality | 1 | 2006 | 1275 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1993 | 906 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1990 | 1354 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1999 | 12207 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5300 | 0.010 |
Why?
|
| Life Tables | 1 | 1999 | 370 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 1423 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 322 | 0.010 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2000 | 80 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 277 | 0.010 |
Why?
|
| Health Education | 1 | 2006 | 1056 | 0.010 |
Why?
|
| Utilization Review | 1 | 2000 | 392 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 247 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 285 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2003 | 517 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2000 | 415 | 0.010 |
Why?
|
| Subclavian Vein | 1 | 1998 | 54 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1990 | 2291 | 0.010 |
Why?
|
| ROC Curve | 1 | 2006 | 3528 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1860 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Uterine Hemorrhage | 1 | 1999 | 255 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3252 | 0.010 |
Why?
|
| Zalcitabine | 1 | 1997 | 42 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 2494 | 0.010 |
Why?
|
| Neopterin | 1 | 1997 | 56 | 0.010 |
Why?
|
| Chest Tubes | 1 | 1998 | 150 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1461 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1991 | 2988 | 0.010 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 154 | 0.010 |
Why?
|
| Counseling | 1 | 2005 | 1523 | 0.010 |
Why?
|
| Electrooculography | 1 | 1996 | 118 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 1070 | 0.010 |
Why?
|
| Hand Injuries | 1 | 1999 | 242 | 0.010 |
Why?
|
| Health Facility Size | 1 | 1996 | 64 | 0.010 |
Why?
|
| Foot | 1 | 2000 | 527 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1993 | 8949 | 0.010 |
Why?
|
| Heart Block | 1 | 1998 | 410 | 0.010 |
Why?
|
| North America | 1 | 2000 | 1249 | 0.010 |
Why?
|
| Heart Injuries | 1 | 1998 | 210 | 0.010 |
Why?
|
| Diet | 1 | 2014 | 7937 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 1997 | 194 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1998 | 440 | 0.010 |
Why?
|
| Edema | 1 | 2000 | 789 | 0.010 |
Why?
|
| Confusion | 1 | 1998 | 275 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 483 | 0.010 |
Why?
|
| Dysthymic Disorder | 1 | 1996 | 74 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 1998 | 281 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1998 | 578 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2001 | 838 | 0.010 |
Why?
|
| Emotions | 1 | 1987 | 2659 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 1360 | 0.010 |
Why?
|
| Sick Role | 1 | 1996 | 237 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 482 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2003 | 1486 | 0.010 |
Why?
|
| Brain | 3 | 1999 | 26388 | 0.010 |
Why?
|
| Wheelchairs | 1 | 1995 | 77 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 767 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 2795 | 0.010 |
Why?
|
| Mothers | 1 | 2005 | 2165 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1998 | 379 | 0.010 |
Why?
|
| Decision Trees | 1 | 1996 | 506 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 2684 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2001 | 1530 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6755 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1998 | 662 | 0.010 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1994 | 109 | 0.010 |
Why?
|
| Vagina | 1 | 1999 | 825 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 2045 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 1643 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 168768 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2001 | 1406 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1999 | 988 | 0.010 |
Why?
|
| Management Audit | 1 | 1993 | 23 | 0.010 |
Why?
|
| Lipids | 1 | 2005 | 3307 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1994 | 163 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 1997 | 412 | 0.010 |
Why?
|
| Specialty Boards | 1 | 1995 | 227 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 361 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 1998 | 514 | 0.010 |
Why?
|
| HLA-DR2 Antigen | 1 | 1993 | 48 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 6542 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1999 | 956 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1997 | 403 | 0.010 |
Why?
|
| Lenses, Intraocular | 1 | 1994 | 140 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2005 | 2071 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1999 | 1183 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 418 | 0.010 |
Why?
|
| Organ Size | 1 | 1997 | 2251 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 683 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1995 | 464 | 0.010 |
Why?
|
| Amylases | 1 | 1992 | 173 | 0.010 |
Why?
|
| Ovarian Diseases | 1 | 1993 | 139 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1993 | 235 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1917 | 0.010 |
Why?
|
| Emergencies | 1 | 1998 | 1170 | 0.010 |
Why?
|
| Xylose | 1 | 1991 | 28 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1993 | 277 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20130 | 0.010 |
Why?
|
| Lactose Intolerance | 1 | 1991 | 27 | 0.010 |
Why?
|
| Analgesia, Epidural | 1 | 1994 | 326 | 0.010 |
Why?
|
| Injections, Epidural | 1 | 1993 | 195 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5895 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1991 | 378 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1988 | 5027 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4925 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1994 | 592 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1992 | 520 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1994 | 675 | 0.010 |
Why?
|
| Job Description | 1 | 1990 | 58 | 0.010 |
Why?
|
| Breath Tests | 1 | 1991 | 280 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1982 | 2624 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1990 | 260 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 3922 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13035 | 0.010 |
Why?
|
| Lipase | 1 | 1992 | 314 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2001 | 2974 | 0.010 |
Why?
|
| Computer Simulation | 2 | 1994 | 6194 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 1994 | 696 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 931 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 1245 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1992 | 620 | 0.010 |
Why?
|
| Placebo Effect | 1 | 1993 | 502 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1995 | 881 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1993 | 657 | 0.010 |
Why?
|
| Cataract | 1 | 1995 | 834 | 0.010 |
Why?
|
| Gait | 1 | 1995 | 793 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2002 | 5006 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1994 | 903 | 0.010 |
Why?
|
| Graft Survival | 1 | 1999 | 3737 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 389 | 0.010 |
Why?
|
| Leukemia | 1 | 1997 | 1510 | 0.010 |
Why?
|
| Fertility | 1 | 1993 | 781 | 0.000 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 996 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1993 | 1041 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1998 | 1924 | 0.000 |
Why?
|
| Leukopenia | 1 | 1988 | 213 | 0.000 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1994 | 816 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1999 | 3461 | 0.000 |
Why?
|
| Anesthesia | 1 | 1998 | 1561 | 0.000 |
Why?
|
| Self Administration | 1 | 1988 | 385 | 0.000 |
Why?
|
| Nurse Practitioners | 1 | 1990 | 269 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1993 | 820 | 0.000 |
Why?
|
| Haplotypes | 1 | 1993 | 2779 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2274 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1994 | 2617 | 0.000 |
Why?
|
| T-Lymphocytes | 2 | 1993 | 10183 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2585 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1826 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1990 | 695 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1993 | 1470 | 0.000 |
Why?
|
| Steroids | 1 | 1987 | 930 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2540 | 0.000 |
Why?
|
| Societies, Medical | 1 | 1993 | 3743 | 0.000 |
Why?
|
| Air Pollution | 1 | 1994 | 2286 | 0.000 |
Why?
|
| Education, Medical | 1 | 1990 | 1722 | 0.000 |
Why?
|
| Body Temperature | 1 | 1982 | 777 | 0.000 |
Why?
|
| Curriculum | 1 | 1990 | 3605 | 0.000 |
Why?
|